We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Finasteride

News List

Finasteride Manufacturers, Bulk Price, Market Size and Trend PharmaSources
June 04, 2021
Finasteride belongs to the group of drugs called benign prostatic hypertrophy agents. It is commonly used to manage enlarged prostate and reduce the need for surgery and prevent acute urinary retention. It may also be used for male pattern hair loss.
Sheffield University gets £3.1 mn for trials to better bladder, prostate cancer diagnosis, treatment expresspharma
November 19, 2020
The two trials are part of a wider £8.3 million funding boost for new research programmes across Yorkshire.
Final verdict on finasteride: Safe, effective prevention for prostate cancer worldpharmanews
January 24, 2019
Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT).